Medidata Solutions (MDSO) Earns News Impact Score of 0.33
News stories about Medidata Solutions (NASDAQ:MDSO) have been trending positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medidata Solutions earned a news impact score of 0.33 on Accern’s scale. Accern also gave news articles about the company an impact score of 71 out of 100, indicating that recent news coverage is likely to have an impact on the company’s share price in the next few days.
Several analysts have commented on MDSO shares. Zacks Investment Research cut Medidata Solutions from a “hold” rating to a “sell” rating in a report on Friday, July 21st. Needham & Company LLC restated a “buy” rating and issued a $65.00 price target on shares of Medidata Solutions in a report on Wednesday, April 19th. Piper Jaffray Companies lifted their price objective on Medidata Solutions from $60.00 to $72.00 and gave the company an “overweight” rating in a research note on Tuesday, April 11th. SunTrust Banks, Inc. lifted their price objective on Medidata Solutions from $80.00 to $90.00 and gave the company a “buy” rating in a research note on Tuesday, June 27th. Finally, Morgan Stanley lifted their price objective on Medidata Solutions from $74.00 to $86.00 and gave the company an “overweight” rating in a research note on Thursday, July 20th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $78.17.
Shares of Medidata Solutions (MDSO) traded up 0.59% during trading on Thursday, hitting $77.31. The company’s stock had a trading volume of 509,712 shares. The company has a market capitalization of $4.52 billion, a P/E ratio of 124.69 and a beta of 1.79. Medidata Solutions has a 1-year low of $46.10 and a 1-year high of $85.92. The firm’s 50 day moving average is $77.80 and its 200-day moving average is $65.11.
Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Tuesday, July 18th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.03. The firm had revenue of $137.41 million for the quarter, compared to the consensus estimate of $134.28 million. Medidata Solutions had a return on equity of 11.14% and a net margin of 7.07%. The business’s revenue was up 19.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.24 earnings per share. Analysts forecast that Medidata Solutions will post $1.28 EPS for the current fiscal year.
In other news, Director Robert Taylor sold 5,639 shares of the company’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $73.46, for a total transaction of $414,240.94. Following the completion of the transaction, the director now directly owns 54,372 shares in the company, valued at $3,994,167.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Michael L. Capone sold 5,000 shares of the company’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $69.46, for a total transaction of $347,300.00. Following the transaction, the chief operating officer now owns 171,754 shares of the company’s stock, valued at $11,930,032.84. The disclosure for this sale can be found here. 5.80% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: “Medidata Solutions (MDSO) Earns News Impact Score of 0.33” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/03/positive-news-coverage-likely-to-impact-medidata-solutions-mdso-stock-price-updated-updated-updated.html.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Stock Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related stocks with our FREE daily email newsletter.